% Expired Patents = 16.7

EPO Patents = 4

Forward Citations = 3

Loading Chart...

13 inventors (with patents filed for the assignee):

Jean-Claude Maurel (6 out of 9 patents)

Elsa Compte (3 out of 3 patents)

Cyril Lavaud (2 out of 2 patents)

4. Yannick Guari (1 out of 3 patents)

5. Joulia Guari (1 out of 1 patent)

6. Jérôme Long (1 out of 1 patent)

7. Caroline Bauer (1 out of 1 patent)

8. Olivier Gremy (1 out of 1 patent)

9. Laurent Miccoli (1 out of 1 patent)

10. Jaime Francisco Angulo-Mora (1 out of 2 patents)

11. Lorraine Benigno-Anton (1 out of 1 patent)

12. Sophie Grives-Jerphagnon (1 out of 1 patent)

13. Patrick Maurel (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11793831 - Treatment and prevention of injury due to radiation exposure (2023-10-24),

2. 11278568 - In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system (2022-03-22),

3. 10172954 - Use of a reverse-micellar system for delivering chelators of radionuclides and metals (2019-01-08),

4. 9592218 - Reverse micelle system comprising metal ions and use thereof (2017-03-14),

5. 9452136 - Reverse micelle system comprising nucleic acids and use thereof (2016-09-27),

6. 8877237 - Reverse micelle system comprising nucleic acids and use thereof (2014-11-04),

Medesis Pharma is a leading pharmaceutical company dedicated to improving healthcare outcomes. Our innovative approach to drug development focuses on creating safe and effective treatments for a variety of medical conditions. With a commitment to quality and patient care, we strive to make a positive impact on the global healthcare industry.

Profile summary based on public USPTO records.